An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion , which will decide whether or not to retain it. |
Fausta Shakiwa Mosha (born 14 April 1976) is a Tanzanian Medical Doctor and currently serves as a Senior Laboratory Advisor at the WHO hub for Pandemic and Epidemic Intelligence in Berlin, Germany. Recognized for her extensive work in public health, she has made significant contributions on a global scale, addressing public health crises in Africa, the Middle East, and worldwide.
Born to Chagga parents in Tanga Region, Tanzania, Mosha commenced her education at Tanga International School and later moved to Azimio Primary school, both in Tanga between the year 1982 and 1988. She attended Mbeya and Loleza Secondary Schools respectively from 1989 to 1992, and later on, she graduated from Kilakala and Loleza High School in 1995. She obtained her Medical Doctor degree from Muhimbili University College of Health Sciences, University of Dar es Salaam, and later pursued a master’s in medical sciences and a PhD in Biomedical Sciences from the Catholic University of Leuven, Belgium, and a master's in Field Epidemiology and Laboratory Management from Jomo Kenyatta University, Kenya.
Mosha was the Director for the National Health Laboratory Quality Assurance and Training Centre (NHLQATC) at the Ministry of Health in Tanzania from 2011, leading numerous national and international health projects, including the Proficiency Testing for HIV Rapid Tests and Laboratory Quality Management System Strengthening in various African and Caribbean countries. [1]
Before her current role, Mosha served as a regional advisor for public health laboratories at WHO EMRO, and as a technical officer, laboratory at WHO AFRO. Her leadership in the East Africa Public Health Laboratory Networking Project funded by the World Bank and various cooperative agreements with the US Centers for Disease Control and Prevention has strengthened global health security. [2] [3]
As a Senior Laboratory Advisor at the WHO hub for Pandemic and Epidemic intelligence in Berlin, Germany, Mosha continues to enhance global strategies for pandemic and epidemic preparedness and response.
Dr. Mosha is a founding member of the African Society for Laboratory Medicine (ASLM) and served as the Secretary for the Board of Directors for seven years, contributing significantly to the advancement of laboratory medicine across Africa. [4]
Dr. Mosha's scientific career in biomedical and laboratory science research was honored with the Next Einstein Forum Women Career Scientists Award in 2018. [5] She has also been recognized for her leadership in disease outbreak response, showcasing her capability in managing significant public health crises. [6]
Mosha's scholarly output includes 49 papers and one book chapter, published in prestigious peer-reviewed journals, reflecting her extensive research and expertise in clinical microbiology and field epidemiology. She has been featured on "Africa 54" discussing public health initiatives, highlighting her role in improving disease prevention and preparedness across East Africa. [7]
She is married to Prof. Eliangiringa Amos Kaale, and together they have three children.
The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.
The National Microbiology Laboratory (NML) is part of the Public Health Agency of Canada (PHAC), the agency of the Government of Canada that is responsible for public health, health emergency preparedness and response, and infectious and chronic disease control and prevention.
The Health Protection Agency (HPA) was a non-departmental public body in England. It was set up by the UK government in 2003 to protect the public from threats to their health from infectious diseases and environmental hazards.
The Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest and largest medical research bodies in the world.
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.
The National Centre for Disease Control is an institute under the Indian Directorate General of Health Services, Ministry of Health and Family Welfare. It was established in July 1963 for research in epidemiology and control of communicable diseases and to reorganize the activities of the Malaria Institute of India. It has nine branches at Alwar, Bengaluru, Trivandrum, Calicut, Coonoor, Jagdalpur, Patna, Rajahmundry and Varanasi to advise the respective state governments on public health. The headquarters are in Sham Nath Marg, in New Delhi.
The United States Biological Defense Program—in recent years also called the National Biodefense Strategy—refers to the collective effort by all levels of government, along with private enterprise and other stakeholders, in the United States to carry out biodefense activities.
Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. Previously, from October 2017 to March 2019, she was the Deputy Director General of Programmes (DDP) at the World Health Organization.
Thomas J. Coates is the Director of the multi-campus University of California Global Health Institute, a UC-wide initiative established to improve health and reduce the burden of disease throughout the world. He is Professor Emeritus at the UCLA David Geffen School of Medicine and Founding Director of the UCLA Center for World Health, a joint initiative of the David Geffen School of Medicine at UCLA and UCLA Health, He has conducted extensive research in the realm of HIV and is the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the Division of Infectious Diseases at UCLA and Distinguished Professor of Medicine. Health-related behavior is of particular interest to Coates. Throughout his career as a health expert, his theory-based research has been focused on interventions aimed at reducing risks and threats to health
The Nigeria Centre for Disease Control and Prevention (NCDC) is the national public health institute for Nigeria. It is a federal government agency under the Federal Ministry of Health (Nigeria), with its headquarters in Abuja, Federal Capital Territory.
Deborah Leah Birx is an American physician and diplomat who served as the White House Coronavirus Response Coordinator under President Donald Trump from 2020 to 2021. Birx specializes in HIV/AIDS immunology, vaccine research, and global health. Starting in 2014, she oversaw the implementation of the President's Emergency Plan for AIDS Relief (PEPFAR) program to support HIV/AIDS treatment and prevention programs in 65 countries. From 2014 to 2020, Birx was the United States global AIDS coordinator for presidents Barack Obama and Donald Trump and served as the United States special representative for global health diplomacy between 2015 and 2021. Birx was part of the White House Coronavirus Task Force from February 2020 to January 2021. In March 2021, Birx joined ActivePure Technology as Chief Medical and Science Advisor.
Raj Panjabi is an American physician, entrepreneur, professor and former White House official.
Stephen C. Redd is a U.S. physician and rear admiral with the U.S. Public Health Service and an Assistant Surgeon General. With over 30 years of public health and executive leadership experience, Redd served as the Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention. Previously, he was the Director of the CDC's Influenza Coordination Unit, where he served as the incident commander for the 2009-2010 H1N1 pandemic influenza response.
Thomas M. Kariuki is a Kenyan biologist who is Chief Executive Officer of the Science for Africa Foundation. Kariuki previously served as the Director of Programmes for the Alliance for Accelerating Excellence in Science in Africa (AESA). He was the Director of the Institute of Primate Research/National Museums of Kenya, for seven years. Kariuki’s research interests have spanned the immunology of neglected infectious diseases and he has been involved in global efforts to develop vaccines, drugs and diagnostics for poverty-related diseases. He has published on vaccines and diagnostics development for schistosomiasis (Bilharzia), malaria and co-infections and on policy issues related to biomedical research and funding. He is a Fellow of the African Academy of Sciences (AAS), Senior Fellowship of the European Foundations Initiative for Neglected Tropical Diseases, Presidential honour of the Order of Grand Warrior of Kenya (OGW) for scientific leadership and public service, Honorary Professor of Research of the Liverpool School of Tropical Medicine, LSTM.
Alash'le Grace Abimiku is a Nigerian executive director of the International Research Centre of Excellence at the Institute of Human Virology Nigeria and a professor of virology at the University of Maryland School of Medicine who takes interest in the prevention and treatment of HIV.
Alexandra Louise Phelan is an associate professor at Johns Hopkins Bloomberg School of Public Health and senior scholar at the Johns Hopkins Center for Health Security. She specializes in international legal and policy issues that are related to emerging and reemerging infectious diseases, including upstream drivers of disease emergence like climate change.
The Africa Centres for Disease Control and Prevention is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats. The idea of an African CDC was proposed by the government of Ethiopia in 2013, during a TB/HIV special summit in Abuja, Nigeria. From 2013 to 2016, the modalities and statute of Africa CDC were developed, and the specialized agency was officially launched in January 2017.
Maria Petronella Gerarda Koopmans is a Dutch virologist who is Head of the Erasmus MC Department of Viroscience. Her research considers emerging infectious diseases, noroviruses and veterinary medicine. In 2018 she was awarded the Netherlands Organisation for Scientific Research (NWO) Stevin Prize. She serves on the scientific advisory group of the World Health Organization.
Sylvie Champaloux Briand is a French physician who is Director of the Pandemic and Epidemic Diseases Department at the World Health Organization. Briand led the Global Influenza Programme during the 2009 swine flu pandemic. During the COVID-19 pandemic, Briand launched the WHO Information Network for Epidemics which looked to counter the spread of COVID-19 misinformation.
John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.